Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. - Wikidata - wikimedia - TriplyDB

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

http://www.wikidata.org/entity/Q50954069

about

Ethical challenges with the left ventricular assist device as a destination therapy The future of left ventricular assist devices Left ventricular assist device patient selection: do risk scores help?Mechanical Ventricular Assistance as Destination Therapy for End-Stage Heart Failure: Has it Become a First Line Therapy?Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction Temporary mechanical circulatory support: a review of the options, indications, and outcomes Functional status in left ventricular assist device-supported patients: a literature review Left ventricular assist devices as a bridge to cardiac transplantation.Inhaled therapy for the management of perioperative pulmonary hypertension Mechanical Circulatory Support for the Failing Heart: Continuous-Flow Left Ventricular Assist Devices.Left ventricular assist devices-current state and perspectives Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment Current state-of-the-art of device therapy for advanced heart failure Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry Management of end-stage heart failure: a perspective on the Arab Gulf states Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy-Challenges to Measuring Impact and Change in Institutional Culture.Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy The Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary results OPTN/SRTR 2011 Annual Data Report: heart.Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support.Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction Chronic heart failure: contemporary diagnosis and management Preoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation.Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation.Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation.Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.Early adverse events as predictors of 1-year mortality during mechanical circulatory support.Assessing technological change in cardiothoracic surgery.Predictors of hospital length of stay after implantation of a left ventricular assist device: an analysis of the INTERMACS registry.Mechanical circulatory support as a bridge to transplant or for destination therapy.Survival analysis of patients with heart failure: implications of time-varying regression effects in modeling mortality.Initial experience with off-pump left ventricular assist device implantation in single center: retrospective analysis Cardiac Health Risk Stratification System (CHRiSS): a Bayesian-based decision support system for left ventricular assist device (LVAD) therapy.Cardiac T-Tubule Microanatomy and Function.How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial Predictors of right ventricular failure after left ventricular assist device implantation.Right ventricular function and left ventricular assist device placement: clinical considerations and outcomes.HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis.

P2860

Q21203533-B6EA96E0-2D6A-4E1F-AB06-FA6A80F58F96 Q26770276-452CDECB-B5F4-4287-B41B-4F9C597DFDDB Q26770320-A4A577C0-D64C-4B1B-8833-B5DB2A0BE741 Q26797254-19E1B940-AD5D-43A1-95DB-678CEDBA8E3E Q26824420-E079247F-1441-4B2A-B0E7-A0001166A9DA Q26824537-2F56B85A-99C3-49EB-B4A0-9367526C2BEC Q26995718-89CB52E8-B1E5-42B3-90F1-7ED4C9AA684E Q26999337-FB7F0200-8F2B-496C-A953-5CA509E1A0AA Q27026522-3B302323-AD24-4A9E-ACDB-E161DF962E37 Q28071544-0422F447-3445-4C20-94B5-92F362BC86A9 Q28074655-54A12505-6202-4AC6-A23C-2A1156155EDE Q28075310-02C491EE-35D9-46C3-B389-918EE282EE86 Q28081412-840DA958-1047-4FF2-B801-22119D9A87A6 Q28648127-892096AA-9301-430B-AE0E-010B7A6C084A Q28751716-C9A48AD6-5A34-458D-B8FD-06769309E9E4 Q30151465-79164F89-064E-4396-9ACA-C405C72F7DD8 Q30226555-04D978E5-A211-49C7-8FA1-563DD0F0DA9E Q30359726-D7FBAB34-998D-4868-A6E9-B8CC65BD2818 Q30581476-F05BE6BC-E3D4-4100-83C7-AE97C4B733D8 Q31149536-89F24EE0-0B92-465C-9C43-6BE5246FD567 Q33390013-5960C698-C946-4191-8CF9-B11D5A769A3D Q33552944-9F83BC1A-0B70-45A8-BB79-B1CF8DBA16B9 Q33620431-7C1E7274-9CA8-45DA-8BA0-7022F2B3A7D9 Q33818484-B19441EF-7BD6-4C16-97D7-C0866F49A871 Q33818507-BA3DAADE-A7FD-4CE9-9965-0D9F745648C8 Q33920259-EA7AF65D-D7CC-432D-9A43-FD34791FDEA6 Q33951313-7A48F9A8-A15B-43BF-B332-A06ED207FC09 Q33951353-C081099D-07F8-496E-866E-BAAAF7208E10 Q34079591-AABA97FC-8F09-49D5-8EE5-FA6D21D88EFE Q34111912-2375FCC2-2C09-4C51-96AB-4F001EC669D3 Q34240752-3876D06A-929C-4CD4-B356-D68447315A2B Q34268754-CE486302-06CA-474D-A8E4-0DD61ED4E6E8 Q34310212-9793299E-C3FC-4651-AEE3-4712F40C9E57 Q34467873-24E0C341-6E80-40B8-8BD0-A9296E351E58 Q34513055-C052C4D5-EA03-4ACC-8563-994AF833D7CE Q34545692-E72448D9-0515-4D58-B5AB-77A4B5723041 Q34609578-56F0E94E-6353-44B6-85C0-C482C9572E1E Q34965572-0F74FDDD-8FB7-45A5-AF43-09B86DE8AEAD Q34986270-C108E9F9-FEB8-4C02-822C-D1F9DD5B5177 Q35029983-6762F976-595B-4FC0-9853-BE56209C1FD8

P2860

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

http://www.wikidata.org/entity/Q50954069

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Outcomes of left ventricular a ...... cations for patient selection.

@en

Outcomes of left ventricular a ...... cations for patient selection.

@nl

type

label

Outcomes of left ventricular a ...... cations for patient selection.

@en

Outcomes of left ventricular a ...... cations for patient selection.

@nl

prefLabel

Outcomes of left ventricular a ...... cations for patient selection.

@en

Outcomes of left ventricular a ...... cations for patient selection.

@nl

P1433

Q50954069-245E7C5D-1E66-436D-8867-94C403E450DF

P1476

Q50954069-37EAE84C-F3D0-420C-8B2D-DB7D2E353435

P2093

Q50954069-0028C552-2FE8-4292-B0B5-0434490A349E

Q50954069-14E204CF-E625-429C-86E4-508DDE14BF77

Q50954069-3A219E3A-84B1-405F-89B0-BBDD424BC860

Q50954069-7A79FD0F-7F2F-4231-B494-F9BF85152B45

Q50954069-A6AC7A6C-27AE-4F6E-B64E-B4AB6FB6FCEE

Q50954069-A9DB22CD-08A9-4344-9F02-58EBE744CAA7

Q50954069-B3246786-3B20-488F-9F61-81771BB4BE39

Q50954069-BE8E6281-C8E6-4659-84DF-504B441D0F7E

Q50954069-E24A5EBF-820C-48F9-93AF-5309D436793B

Q50954069-FB12019F-681F-4DCA-85DF-9863FFE58F53

P304

Q50954069-76E5E5C0-4C5B-4947-90BD-8828C810165A

P31

Q50954069-D9D35B70-3CA5-40EF-9D13-9360CDA14129

P356

Q50954069-D5EC1E9E-0F4F-4342-B780-A7C1DC7DFE4A

P407

Q50954069-A62FA6AB-F69F-479F-8C86-9F591269CBE3

P433

Q50954069-42A1059C-7C11-4863-B3A4-66858A3FDB0B

P478

Q50954069-4B6E05D8-C3A6-4290-96B5-343255159541

P577

Q50954069-BAE80E11-8822-45E9-8EA9-FC234CF0B5F3

P698

Q50954069-2652908B-ADA3-4311-A4D4-B4E7DA7747A2

P921

Q50954069-CEB8A074-F99B-4DF1-A5BB-1ED5F8B27565

P356

CIRCULATIONAHA.107.691972

P1433

P1476

Outcomes of left ventricular a ...... cations for patient selection.

@en

P2093

Abdallah G Kfoury

http://www.w3.org/2001/XMLSchema#string

Carmelo A Milano

http://www.w3.org/2001/XMLSchema#string

Donna Mancini

http://www.w3.org/2001/XMLSchema#string

James W Long

http://www.w3.org/2001/XMLSchema#string

Joseph G Rogers

http://www.w3.org/2001/XMLSchema#string

Katherine Lietz

http://www.w3.org/2001/XMLSchema#string

Leslie W Miller

http://www.w3.org/2001/XMLSchema#string

Marc A Silver

http://www.w3.org/2001/XMLSchema#string

Mark S Slaughter

http://www.w3.org/2001/XMLSchema#string

Yoshifumi Naka

http://www.w3.org/2001/XMLSchema#string

P304

497-505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.107.691972

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17638928

http://www.w3.org/2001/XMLSchema#string

P921